

A Tumor Imaging Platform Supported by AI to Improve Cancer Surgery
Coming Soon to the Operating Theaters Near You
A New Intraoperative Tool in Cancer Margin Imaging
​
​At 3Sonic, we’re transforming the way cancer surgeries are performed. By combining real-time 3D ultrasound imaging with advanced AI, our platform enables rapid margin assessment of surgical specimens—directly inside the operating room. Faster decisions. Greater precision. Better outcomes.
Innovative Cancer Tumor Imaging Platform:
Designed for real-time, instant use in the operating room
Substantial Market Opportunity:
Targeted market potential of $13 billion, addressing significant demand in global medical imaging sector.

Proven Clinical Efficacy:
Clinical proof of concept completed with oral cancer patients.
Enhanced Patient Outcomes and Cost Efficiency:
Boosts surgical precision and reduces treatment-related costs
Advanced Prototype Development:
Fully functional prototype of imaging platform constructed.
Attractive to Investors:
Compelling opportunity for venture capital funding to fuel further development and market penetration.
